Literature DB >> 26335088

Response to psychotherapy for posttraumatic stress disorder: the role of pretreatment verbal memory performance.

Mirjam J Nijdam1, Giel-Jan de Vries, Berthold P R Gersons, Miranda Olff.   

Abstract

OBJECTIVE: Neuropsychological studies have consistently demonstrated impaired verbal memory in posttraumatic stress disorder (PTSD). Trauma-focused treatment for PTSD is thought to rely on memory, but it is largely unknown whether treatment outcome is influenced by memory performance. The aim of the study, therefore, was to examine the relationship between verbal memory performance and treatment response to trauma-focused psychotherapy.
METHOD: Participants were referred to our outpatient clinic and recruited between December 2003 and January 2009 upon diagnosis of PTSD according to DSM-IV. Secondary analyses of a randomized controlled trial comparing eye movement desensitization and reprocessing therapy (n = 70) and brief eclectic psychotherapy (n = 70), a cognitive-behavioral intervention, are reported. Response to treatment was measured by self-reported PTSD symptom severity (Impact of Event Scale-Revised) over 17 weeks. Pretreatment verbal memory measures (California Verbal Learning Test, Rivermead Behavioral Memory Test) were included in the mixed linear model analyses in order to investigate the influence of memory on treatment outcome.
RESULTS: Pretreatment encoding, short-term retrieval, long-term retrieval, and recognition performance were significantly associated with treatment response in terms of self-reported PTSD symptom severity for both treatments (P ≤ .013). Receiver operating characteristic curves predicting treatment response with pretreatment memory indices showed that 75.6% of the patients could be correctly classified as responder.
CONCLUSIONS: Poor verbal memory performance represents a risk factor for worse treatment response to trauma-focused psychotherapy. Memory measures can be helpful in determining which patients are unable to benefit from trauma-focused psychotherapy. Future research should explore how treatment perspectives of patients with poor verbal memory can be improved. CLINICAL TRIALS REGISTRATION: ISRCTN.com identifier: ISRCTN64872147. © Copyright 2015 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26335088     DOI: 10.4088/JCP.14m09438

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  16 in total

1.  Using fMRI connectivity to define a treatment-resistant form of post-traumatic stress disorder.

Authors:  Amit Etkin; Adi Maron-Katz; Wei Wu; Gregory A Fonzo; Julia Huemer; Petra E Vértes; Brian Patenaude; Jonas Richiardi; Madeleine S Goodkind; Corey J Keller; Jaime Ramos-Cejudo; Yevgeniya V Zaiko; Kathy K Peng; Emmanuel Shpigel; Parker Longwell; Russ T Toll; Allison Thompson; Sanno Zack; Bryan Gonzalez; Raleigh Edelstein; Jingyun Chen; Irene Akingbade; Elizabeth Weiss; Roland Hart; Silas Mann; Kathleen Durkin; Steven H Baete; Fernando E Boada; Afia Genfi; Jillian Autea; Jennifer Newman; Desmond J Oathes; Steven E Lindley; Duna Abu-Amara; Bruce A Arnow; Nicolas Crossley; Joachim Hallmayer; Silvia Fossati; Barbara O Rothbaum; Charles R Marmar; Edward T Bullmore; Ruth O'Hara
Journal:  Sci Transl Med       Date:  2019-04-03       Impact factor: 17.956

2.  Patient recall of specific cognitive therapy contents predicts adherence and outcome in adults with major depressive disorder.

Authors:  Lu Dong; Xin Zhao; Stacie L Ong; Allison G Harvey
Journal:  Behav Res Ther       Date:  2017-08-10

Review 3.  A role for deficits in GABAergic neurosteroids and their metabolites with NMDA receptor antagonist activity in the pathophysiology of posttraumatic stress disorder.

Authors:  Ann M Rasmusson; Suzanne L Pineles; Kayla D Brown; Graziano Pinna
Journal:  J Neuroendocrinol       Date:  2021-12-28       Impact factor: 3.870

4.  Neurocognitive predictors of treatment outcomes in psychotherapy for comorbid PTSD and substance use disorders.

Authors:  J Cobb Scott; Kevin G Lynch; David P Cenkner; Shannon M Kehle-Forbes; Melissa A Polusny; Ruben C Gur; Shirley Chen; Edna B Foa; David W Oslin
Journal:  J Consult Clin Psychol       Date:  2021-11

Review 5.  Neurocognitive and Information Processing Biases in Posttraumatic Stress Disorder.

Authors:  Jennifer J Vasterling; Kimberly A Arditte Hall
Journal:  Curr Psychiatry Rep       Date:  2018-09-17       Impact factor: 5.285

6.  Predicting and Managing Treatment Non-Response in Posttraumatic Stress Disorder.

Authors:  Gregory A Fonzo; Vecheslav Federchenco; Alba Lara
Journal:  Curr Treat Options Psychiatry       Date:  2020-03-23

7.  Erasing memory traces of trauma with eye movement desensitization and reprocessing therapy.

Authors:  Mirjam J Nijdam; Miranda Olff
Journal:  Eur J Psychotraumatol       Date:  2016-07-04

8.  Moving forward in treatment of posttraumatic stress disorder: innovations to exposure-based therapy.

Authors:  Mirjam J Nijdam; Eric Vermetten
Journal:  Eur J Psychotraumatol       Date:  2018-05-18

9.  An Innovative Framework for Delivering Psychotherapy to Patients With Treatment-Resistant Posttraumatic Stress Disorder: Rationale for Interactive Motion-Assisted Therapy.

Authors:  Marieke J van Gelderen; Mirjam J Nijdam; Eric Vermetten
Journal:  Front Psychiatry       Date:  2018-05-04       Impact factor: 4.157

10.  Baseline Cognitive Performance and Treatment Outcomes From Cognitive-Behavioral Therapies for Posttraumatic Stress Disorder: A Naturalistic Study.

Authors:  Kaloyan S Tanev; Lydia E Federico; Mark S Greenberg; Scott P Orr; Elizabeth M Goetter; Patricia A Resick; Roger K Pitman
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2020-01-17       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.